These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases. Aerts JM; Hollak CE; van Breemen M; Maas M; Groener JE; Boot RG Acta Paediatr Suppl; 2005 Mar; 94(447):43-6; discussion 37-8. PubMed ID: 15895711 [TBL] [Abstract][Full Text] [Related]
6. Recapture Lysosomal Enzyme Deficiency via Targeted Gene Disruption in the Human Near-Haploid Cell Line HAP1. Brown A; Zhang J; Lawler B; Lu B Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356092 [TBL] [Abstract][Full Text] [Related]
7. Ambroxol improves skeletal and hematological manifestations on a child with Gaucher disease. Jiang W; Yi M; Maegawa GHB; Zhang H J Hum Genet; 2020 Mar; 65(3):345-349. PubMed ID: 31822786 [TBL] [Abstract][Full Text] [Related]
8. Is Parkinson's disease a lysosomal disorder? Klein AD; Mazzulli JR Brain; 2018 Aug; 141(8):2255-2262. PubMed ID: 29860491 [TBL] [Abstract][Full Text] [Related]
9. Emerging links between pediatric lysosomal storage diseases and adult parkinsonism. Ysselstein D; Shulman JM; Krainc D Mov Disord; 2019 May; 34(5):614-624. PubMed ID: 30726573 [TBL] [Abstract][Full Text] [Related]
14. The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme. Mistry PK; Cox TM J Med Genet; 1993 Nov; 30(11):889-94. PubMed ID: 8301642 [No Abstract] [Full Text] [Related]
15. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology. Gonzalez A; Valeiras M; Sidransky E; Tayebi N Mol Genet Metab; 2014 Feb; 111(2):84-91. PubMed ID: 24389070 [TBL] [Abstract][Full Text] [Related]
16. [Molecular diagnosis and gene therapy for Gaucher disease]. Ohashi T Nihon Rinsho; 1993 Sep; 51(9):2300-7. PubMed ID: 8411706 [TBL] [Abstract][Full Text] [Related]
17. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045 [TBL] [Abstract][Full Text] [Related]
19. A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder. Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E J Clin Invest; 1990 Jan; 85(1):219-22. PubMed ID: 2295698 [TBL] [Abstract][Full Text] [Related]
20. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease. Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]